• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Clinical Relevance of Novel Angiotensin II Generation Pathway within the Kidney

Research Project

Project/Area Number 09470240
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKeio University

Principal Investigator

SARUTA Takao  Keio University, School of Medicine, Professor, 医学部, 教授 (70051571)

Co-Investigator(Kenkyū-buntansha) HONDA Masanori  Keio University, School of Medicine, Assistant, 医学部, 助手 (20270514)
KUBOTA Eiji  Keio University, School of Medicine, Assistant, 医学部, 助手 (40255451)
MATSUDA Hiroto  Keio University, School of Medicine, Assistant, 医学部, 助手 (80245498)
HAYASHI Koichi  Keio University, School of Medicine, Assist.Prof., 医学部, 講師 (80164937)
藤原 啓二  慶應義塾大学, 医学部, 助手 (80255463)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥6,500,000 (Direct Cost: ¥6,500,000)
Fiscal Year 1998: ¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 1997: ¥3,900,000 (Direct Cost: ¥3,900,000)
Keywordschymase / angiotensin / kidney / afferent arterioles / efferent arterioles / renal hemodynamics / dexamethasone / microscopy
Research Abstract

Although angiotensin converting enzyme (ACE) inhibitors retard the progression of renal diseases, it remains undetermined whether a non-ACE-mediated pathway contributes to the angiotensin (ANG) ii generation within the kidney This study attempted to clarify the role of ACE and non-ACE pathway, including chymase, for ANG II generation within the kidney. ANG II generation via ACE-mediated and non-ACE-mediated pathways was examined. The ratio of ACE/non-ACE-mediated ANG II generation was 8 : 2 in dog renal cortex, whereas in the heart this value proved to be 4 : 6. In the kidney, when compared with the effects of intrarenally administered ANG I and [Pro^<11>, D-Ala^<12>]-ANG I (S) (an ANG I analog that cannot be converted to ANG II by ACE) on systemic blood pressure (BP) and renal blood flow (RBF), S required 100-fold higher concentrations to obtain the same degree of changes in BP and RBF.Further studies using intravital needle-type CCD camera microscopy demonstrated that renal afferent and efferent arteriolar actions of S were diminished, compared with those of ANG I.S at a dose of 100 nmol caused 30% decrements in RBF, which was completely abolished by an ANG receptor antagonist, but was only 50% inhibited by chymostatin. Finally, unlike systemic vascular beds, dexamethasone dilates the renal vasculature, which is associated with a decrease in renal interstitial ANG II formation and the paralleled inhibition of renal ACE activity, suggesting glucocorticoid does not affect non-ACE-mediated ANG II generation. Collectively, non-ACE activity, compared with ACE activity, contributes less to the renal ANG II generation, and chymase-mediated ANG II generation shares only half of the non-ACE-mediated ANG II production. Furthermore, non-ACE pathway does not play an important role in ANG II formation in glucocorticoid-treated kidneys Nevertheless, further studies are required to establish the role of non-ACE-mediated renal ANG II formation under a variety of renal diseases.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (22 results)

All Other

All Publications (22 results)

  • [Publications] Murakami M: "Role of angiotenisn II generated by angiotensin converting enzyme-independent pathways in canine kidney" Kidney International. 52. s132-s135 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Takenaka T: "Cellular mechanisms medating rat renal microvascular constirction by angiotensin II." Journal of Clinical Investigation. 100. 2107-2114 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 林 晃一: "腎障害を有する高血圧に対するACE阻害薬とAII拮抗薬 : アンジオテンシン変換酵素とアンジオテンシン受容体拮抗薬" 循環器科. 43. 38-44 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Saruta T: "Recent treatment of hypertension in Japan and JNC-V" Asian Medical Journal. 41. 510-515 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Saruta T: "Current status of calcium antagonists in Japan" The American Journal of Cardiology. 82. 32-34 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ozawa Y: "Renal afferent and efferent arteriolar dilation bynilvadipine : studies in the isolated perfused hydronephrotic kidney" J Cardiovascular Pharmacology. 33. 243-247 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Hayashi K: "Calcium Antagonists in Clinical Medicine 100" Hanley & Belfus, Inc., eds.By Epstein M, 393-411 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Murakami M,et al.: "Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney." Kidneyint. 52. s132-s135 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Murakami M,al.: "Role of angiotensin II generated by an ACE independent pathway in canine kidney." Nephrology. 3. S53 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Takenaka T,et al.: "Cellular mechanisms medating rat renal microvascular constriction by angiotensin II." J Clin Inveest. 100. 2107-2114 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Saruta T,et al.: "Recent treatment of hypertension in Japan" Am J Cardiol. 82. 32-34 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Kubota E,et al.: "Intrarenal angiotensin II as a deteminant of glucocorticoid-induced renal vasodilation." J Am Soc Nephrol. 9. 341A (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ozawa Y,et al.: "Renal afferent and efferent arteriolar dilation by nilvadipine : studies in the isolated perfused hydronephrotic kidney." J Cardiovasc Pharmacol. 33. 243-247 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Murakami M: "Role of angiotenisn II generated by angiotensin converting enzyme-independent pathways in canine kidney." Kidney International. 52. s132-s135 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Takenaka T: "Cellular mechanisms medating rat renal microvascular constirction by angiotensin II." Journal of Clinical Investigation. 100. 2107-2114 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Matsuda H: "Role of bradykinin in angiotensin converting enzyme inhibitor induced dilation of renal microvessels in vivo" Journal of Hypertension. 16. s136 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Matsuda H: "Potential role of endothelium-derived hyperpolarizing factor(EDHF)induced by ACE-I in renal microcirculation in vivo." Journal of American Society of Nephrology. 9. 342 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 林 晃一: "腎障害を有する高血圧に対するACE阻害薬とAII拮抗薬:アンジオテンシン変換酵素とアンジオテンシン受容体拮抗薬" 循環器科. 43. 38-44 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 林 晃一: "腎疾患におけるAII拮抗薬とACE阻害薬の比較" 血圧. 5. 577-580 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Murakami M: "Role of angiotenisn II generated by angiotensin converting enzyme-independent pathways in canine kidney." Kidney International. 52. s132-s135 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Takenaka T: "Cellular mechanisms medating rat renal microvascular constirction by angiotensin II." Journal of Clinical Investigation. 100. 2107-2114 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 林晃一: "腎障害を有する高血圧に対するACE阻害薬とAII拮抗薬:アンジオテンシン変換酵素とアンジオテンシン受容体拮抗薬" 循環器科. 43. 38-44 (1998)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi